holoxan 1000 mg/1 viala prašak za rastvor za injekciju
co.medprom d.o.o. - ифосфамид - prašak za rastvor za injekciju - 1000 mg/1 viala - 1 bočica sa praškom za rastvor za injekciju sadrži: 1000 mg ifosfamid
holoxan 2000 mg/1 viala prašak za rastvor za injekciju
co.medprom d.o.o. - ифосфамид - prašak za rastvor za injekciju - 2000 mg/1 viala - 1 bočica sa praškom za rastvor za injekciju sadrži: 2000 mg ifosfamid
eracid 500 mg/1 tableta filmom obložena tableta
farmavita d.o.o. sarajevo - klaritromicin - filmom obložena tableta - 500 mg/1 tableta - 1 filmom obložena tableta sadrži: 500 mg klaritromicin
eracid 250 mg/1 tableta filmom obložena tableta
farmavita d.o.o. sarajevo - klaritromicin - filmom obložena tableta - 250 mg/1 tableta - 1 filmom obložena tableta sadrži: 250 mg klaritromicin
bivacyn 3500 i.j./1 g+ 500 i.j./1 g mast
sandoz d.o.o. - бацитрацин, neomicin - mast - 3500 i.j./1 g+ 500 i.j./1 g - 1 g masti sadrži: 3 500 iu neomicin (u obliku neomicin sulfata) 500 iu bacitracin
bimanox 2 mg/1 ml kapi za oko, otopina
farmis d.o.o. sarajevo - brimonidin - kapi za oko, otopina - 2 mg/1 ml - 1 ml kapi za oko, otopine sadrži: 2 mg brimonidin tartarata (što odgovara 1,3 mg brimonidina)
travazol 0.15 g/15 g+ 0.015 g/15 g krema
tuzlafarm d.o.o. tuzla - diflukortolon, izokonazol - krema - 0.15 g/15 g+ 0.015 g/15 g - 15 g kreme sadrži: 0,15 g izokonazol nitrat 0,015 g diflukortolon valerat
brimabene 2 mg/ml kapi za oko, otopina
pharmaselect international beteiligungs gmbh, ernst-melchior gasse 20, beč, austrija - brimonidintartarat - kapi za oko, otopina - 2 mg/ml - urbroj: jedan ml otopine sadrži 2 mg brimonidintartarata, što odgovara 1,3 mg brimonidina
taptiqom 15 mikrograma/ml + 5 mg/ml, kapi za oko, otopina
santen oy, niittyhaankatu 20, tampere, finska - tafluprost timolol - kapi za oko, otopina - 15 mcg/ml + 5 mg/ml - urbroj: jedan ml otopine sadrži 15 mikrograma tafluprosta i 5 mg timolola (u obliku maleata)
bimzelx
ucb pharma s.a. - bimekizumab - psorijaza - imunosupresivi - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.